awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38365848-0844805A-9353-437C-B5CD-114BA734283F
Q38365848-0844805A-9353-437C-B5CD-114BA734283F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38365848-0844805A-9353-437C-B5CD-114BA734283F
Benefits and risks of combining anti-tumor necrosis factor with immunomodulator therapy in pediatric inflammatory bowel disease.
P2860
Q38365848-0844805A-9353-437C-B5CD-114BA734283F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38365848-0844805A-9353-437C-B5CD-114BA734283F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1dc7f5c1fd9145a948b71f338f39d53d48599d4f
P2860
A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease.